![1]()
News
Sotagliflozin’s HFpEF benefit confirmed by new analyses
May 24, 2021
A meta-analysis of two pivotal trials for the SGLT1/2 inhibitor sotagliflozin prospectively documents a HFpEF benefit.
![1]()
News
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
May 18, 2021
A prespecified, exploratory analysis from the FIDELIO-DKD trial showed that the nonsteroidal MRA finerenone significantly cut new-onset AFib.
![1]()
News
Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit
May 18, 2021
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.
![1]()
News
PARADISE-MI: Sacubitril/valsartan can’t beat ramipril in patients with acute MI
May 15, 2021
When treating patients with no history of heart failure within days of an acute myocardial infarction, sacubitril/valsartan showed safety but no clear superiority to ramipril.
![1]()
News
Update in Hospital Medicine relays important findings
May 13, 2021
Two panelists highlighted the year of research in areas most relevant and important to hospital medicine.
News
Reassuring data on impact of mild COVID-19 on the heart
May 12, 2021
“Mild COVID-19 left no measurable cardiovascular impact on LV structure, function, scar burden, aortic stiffness, or serum biomarkers.”
News
Infective endocarditis with stroke after TAVR has ‘dismal’ prognosis
May 7, 2021
More than half die during the index hospitalization and two-thirds within the first year, a new study shows.
News
Nutritional support may be lifesaving in heart failure
May 6, 2021
Patients with high-risk chronic heart failure given individualized nutritional support in-hospital had lower mortality following discharge, a new analysis shows.
![1]()
News
Hypertension worsened by commonly used prescription meds
May 6, 2021
Close to 20% of U.S. adults with hypertension are on a prescription drug, such as NSAIDs, known to raise blood pressure, creating an opportunity for drug substitution.
![1]()
News
Torsemide over furosemide as first-line loop diuretic for HF
May 5, 2021
One “Thing We Do for No Reason” is use furosemide rather than torsemide as loop diuretic for patients with heart failure, said Dr. Anthony Breu.
